BeOne Medicines AG (ONC) Competitors & Peers
The 5 largest companies in the same industry as BeOne Medicines AG, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $506.37 | P/E 29.4RSI 40Cap 128.3 B |
| REGN | Peer | $784.57 | P/E 19.4RSI 48Cap 80.8 B |
| ARGX | Peer | $996.99 | P/E 38.0RSI 53Cap 62.1 B |
| RVMD | Peer | $190.15 | RSI 35Cap 40.8 B |
| CSLLY | Peer | $31.02 | P/E 18.2RSI 71Cap 60.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- BMYPartner
Bristol Myers BMS partners with BeOne to evaluate oncology combinations.
Model-inferred, unverified — treat as a lead, not evidence - GHCompetitor
Both compete in precision diagnostics and biomarker-guided therapies.
Model-inferred, unverified — treat as a lead, not evidence